首页|期刊导航|Bone Research|The endosteal niche regulates breast cancer cell dormancy in bone:identification of new molecular determinants

The endosteal niche regulates breast cancer cell dormancy in bone:identification of new molecular determinantsOA

中文摘要

Cellular dormancy compromises the long-term survival of breast cancer patients.Bone represents a frequent site for metastasis,where Spindle-shaped N-cadherin+CD45−osteoblasts(SNOs)hold dormant metastatic cells in the endosteal niche with a Notch2-dependent mechanism.In this work,we excluded the involvement of Notch1 in SNO-induced breast cancer cellular dormancy by immunofluorescence/immunohistochemistry and molecular approaches,using breast cancer tissues and cell lines.RNAdSeq in human bone metastatic MDA-MB231 breast cancer cells sorted for Notch1^(HIGH)and Notch2^(HIGH)expression demonstrated that,compared to their low counterpart,only Notch2^(HIGH)cells expressed enriched pathways relevant for the metastatic process,including pluripotency and Hematopoietic Stem Cell(HSC)gene signatures.They expressed the HSC-associated genes CXCR4,CD34 and TIE2 and MDA-MB231 cells enriched in the encoded proteins showed lesser proliferation ability.Reduced incidence of osteolytic lesions was induced by CXCR4^(HIGH)cells intratibially injected in immunocompromised mice,while lower lesion extension was induced by CXCR4^(HIGH)and TIE2^(HIGH)injected cells compared to CXCR4^(LOW)and TIE2^(LOW)cells.Notch2^(HIGH)cells were enriched in endoplasmic reticulum stress and unfolded protein response genes and overexpressed the CD177 protein,while the CD177 ligands,Plaur,Itgam and Ceacam 1,were highly expressed in SNOs.Kaplan-Meier plots showed positive correlation between high expression of CD177,ITGAM and CEACAM 1-but not PLAUR-and overall survival of patients.CD177^(HIGH)cells were also CXCR4^(HIGH),CD34^(HIGH)and Notch2^(HIGH)and proliferated less than CD177^(LOW)cells.These results support the relevance of Notch2 in SNOmediated cellular dormancy and identified new pathways implicated in bone metastatic breast cancer cell quiescence.

Antonio Maurizi;Maria Salbini;Michela Ciocca;Marzia Rea;Giuseppe D.Tocchini-Valentini;Matilde Merolle;Hanna Taipaleenmäki;Christina Møller Andreasen;Manuela Pellegrini;Anna Teti

Department of Biotechnological and Applied Clinical Sciences,University of L’Aquila,L’Aquila,ItalyInstitute of Biochemistry and Cell Biology,National Council of Research,Monterotondo(Rome),ItalyDepartment of Biotechnological and Applied Clinical Sciences,University of L’Aquila,L’Aquila,ItalyDepartment of Biotechnological and Applied Clinical Sciences,University of L’Aquila,L’Aquila,ItalyInstitute of Biochemistry and Cell Biology,National Council of Research,Monterotondo(Rome),Italy European Mouse Mutant Archive(EMMA),INFRAFRONTIER-IMPC,Mouse Clinic,National Council of Research,Monterotondo(Rome),ItalyInstitute of Biochemistry and Cell Biology,National Council of Research,Monterotondo(Rome),ItalyInstitute of Musculoskeletal Medicine,LMU University Hospital,LMU Munich,Planegg-Martinsried,Germany Musculoskeletal University Center Munich,LMU University Hospital,LMU Munich,Planegg-Martinsried,GermanyResearch Unit of Pathology,Department of Clinical Research,University of Southern Denmark,Odense,DenmarkInstitute of Biochemistry and Cell Biology,National Council of Research,Monterotondo(Rome),ItalyDepartment of Biotechnological and Applied Clinical Sciences,University of L’Aquila,L’Aquila,Italy Institute of Biochemistry and Cell Biology,National Council of Research,Monterotondo(Rome),Italy

医药卫生

cellular dormancymetastatic cellsendosteal nichebone metastasisbreast cancermolecular approachesusing

《Bone Research》 2026 (3)

P.902-919,18

supported by the Italian Association for Cancer Research Investigator Grants N.20116 to A.T.and N.2332923 to M.P.

10.1038/s41413-026-00535-3

评论